EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Subretinal Gene Therapy in X-Linked Retinoschisis

Yang Yang, Kang Zhang, Fang Lu

New England Journal of Medicine · 12.11.2026 · 395 (19) · 1970-1972

DOI: 10.1056/nejmc2609517 ↗

Kurz gefasst

Leserbrief in der Zeitschrift New England Journal of Medicine, erschienen am 12.11.2026. Verfasst von Yang Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Ophthalmology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • State Key Laboratory of Eye Health, National Clinical Center for Ocular Diseases, National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China.

Zitieren

APA

Yang, Y., Zhang, K., & Lu, F. (2026). Subretinal Gene Therapy in X-Linked Retinoschisis. New England Journal of Medicine, 395(19), 1970-1972. https://doi.org/10.1056/nejmc2609517

Vancouver

Yang Y, Zhang K, Lu F. Subretinal Gene Therapy in X-Linked Retinoschisis. New England Journal of Medicine. 2026;395(19):1970-1972. doi:10.1056/nejmc2609517

BibTeX
@article{Yang2026,
  author = {Yang, Yang and Zhang, Kang and Lu, Fang},
  title = {Subretinal Gene Therapy in X-Linked Retinoschisis},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {395},
  number = {19},
  pages = {1970--1972},
  doi = {10.1056/nejmc2609517}
}
Kostenlos starten →